- $589.30m
- $643.05m
- $236.35m
OrthoPediatrics Q2 revenue rises 15%, beats estimates
Brief: OrthoPediatrics Q2 EPS USD -0.3
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics beats Q1 revenue estimates, raises 2026 outlook
Brief: OrthoPediatrics Q1 EPS USD -0.45
Brief: Orthopediatrics Enters First Amendment To Credit Agreement On March 31, 2026 - SEC Filing
OrthoPediatrics Q4 EBITDA misses estimates
Brief: OrthoPediatrics Q4 EPS USD -0.43
U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings
OrthoPediatrics Q4 prelim revenue beats; forecasts 2026 revenue of $262 mln-$266 mln
Medical devices maker OrthoPediatrics' Q3 adjusted EBITDA misses estimates
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity
Brief: Orthopediatrics Announces Preliminary Third Quarter 2025 Revenue And Revised 2025 Guidance
OrthoPediatrics Corp's Q3 prelim revenue up 12%
OrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary
OrthoPediatrics Q2 revenue up 16%
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: OrthoPediatrics Q1 Adjusted EBITDA USD -400 Thousand Vs. IBES Estimate USD 358 Thousand